ADCT•benzinga•
Stephens & Co. Maintains Overweight on ADC Therapeutics, Raises Price Target to $8
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 24, 2025 by benzinga